Investing in European Healthcare | What’s on the Horizon for 2022?


Today’s global healthcare marketplace is marked by unprecedented transformation. The seismic shifts in healthcare delivery and drug development during COVID-19 have, in 2021, continued to demonstrate the power and capacity for changes in the market. A deep understanding of future regulatory and political risks is more important than ever. Within this dynamic environment, McDermott’s international health lawyers are passionate about our role in shaping the alliances that will lead to next-generation digital health technologies, new pharmaceuticals and superior healthcare delivery.

In this European guide, you will find an overview of regulatory changes in 2021 and an insight on issues on the horizon in 2022.

If you’re doing something that’s never been done before, or looking to do something better than it’s ever been done before, we’re here to help. Together, we’re pushing boundaries and knocking down barriers to usher in a new age of healthcare.